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ALLERGENIC PRINCIPLES OF POISON IVY
VIII. IMMUNOLOGICAL PROPERTIES OF A HYDROURUSHIOL-
ALBUMIN CONJUGATE* **
H. S. MASON, PH.D.*** AND A. LADA****
The experiments described in this paper represent an attempt to inhibit
sensitization of the allergic contact type with an allergen-protein conjugate.
Chase (1) has already shown that when 2, 4-dinitrochlorobenzene is fed to non-
sensitive animals "a state of resistance may be established against subsequent
experimental sensitization of the skin by the same substance". In a similar
sense, Sulzberger found that previous intracutaneous injection of neoarsphen-
amine could prevent sensitization by intracutaneous injection of that compound
(2). The present study is based upon the concept that circulating antibodies to a
synthetic conjugate of pure protein and pure allergen (of any type) may inhibit
subsequent sensitization to the allergen, and may depress the level of sensitiza-
tion to the allergen where the allergy is already established.
To test this concept, we have chosen 3-n-pentadecylcatechol [a prototype of
the poison ivy allergens (3)1 as the experimental allergen, human serum albumin
as the antigenic protein, and guinea pigs as the test animals. A conjugate between
the allergen and protein was prepared in vitro, then injected into experimental
animals. These animals were subsequently tested for susceptibility toward
sensitization by 3-n-pentadecylcatechol; untreated animals and animals injected
only with protein were used as controls.
PREPARATION OF ALLERGEN-PROTEIN CONJUGATE
To prepare the allergen-protein conjugate, synthetic 3-n-pentadecylcatechol was con
verted to the corresponding o-quinone (4, 5) and 0.30 gram of this quinone was dissolved in
100 ml. of anhydrous, peroxide-free dioxane. Six grams of human albumint were dissolved
in 500 ml. of water buffered at pH 0 with disodium phosphate, and cooled to 0°C. The cold
dioxane solution of the quinone was then added dropwise to that of the albumin, with
gentle stirring, over a period of three hours. After the dioxane had been added, stirring
was continued for an additional half hour. The flask containing the reaction mixture was
placed in a cold room at 5°C overnight; the resultant solution was dialyzed against fre-
quently changed distilled water for twenty-four hours, then filtered. These operations
were also carried out in a cold room at 5°C. The clear pink filtrate so obtained was frozen
and vacuum-dried to an amorphous, water soluble solid.
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Aqueous solutions of the conjugate were spectrophotometrically compared with albumin
solutions containing the same amount of protein nitrogen. The absorption spectra so ob-
tained showed that in the conjugation reaction the o-quinone had been converted to a
bound form of 3-n-pentadecylcatechol, and on the basis of known extinction coefficients
and molecular weights it was calculated that approximately four molecules of 3-n-penta-
decylcatechol were bound to each molecule of albumin. A binding reaction of the type il-
lustrated in the accompanying equation can be postulated on the basis of the studies of H.
Fischer (6)
0 OH
0 HO
NH2
+
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QUANTITATIVE SKIN TESTING
The technic used for performing quantitative skin tests was a modification of
that described by Dunn, Mason, and Smith (3). Experimental doses of the al-
lergen, 3-n-pentadecylcatechol, in acetone were applied with a capillary pipette
of 0.1 ml. capacity and graduated in 0.001 ml. units. This pipette was mounted
in a Guthrie pipette holder, which permitted the whole delivery apparatus to be
raised and lowered with facility. Rubber tubing attached to the top of the
pipette was connected to a suction bottle between delivery of test doses (for
cleaning and drying), and a screw clamp just above the pipette served to com-
press the tubing while solution was being taken up and applied. Brass rings
used to confine the dose to an area of 0.5 cm2 of skin were fitted with brass
hand]es attached to the outer wall of the cylinder. A starch-glycerine sealing
compound was applied to the bottom of the ring by tapping it gently on a flat
piece of glass covered with a film of the material. The ring was then firmly held
against the clipped abdomen of the guinea pig and a measured dose applied, in
this manner, to a known area of skin.
LEVELS OF PRIMARY IRRITANCY AND SENSITIVITY
Using the quantitative patch test procedure described above, it was found
that no guinea pig reacted to an initial 0.9 microgram application of 3-n-penta-
decylcatechol per 0.5 cm2 of skin. On the other hand, all guinea pigs reacted to
initial applications of 25 micrograms of 3-n-pentadecylcatechol per 0.5 cm2 of
skin, and this level was accordingly considered to be within the level of primary
irritancy. For the purposes of this study, subsequent reactivity to an application
of 0.9 microgram per 0.5 cm2 has been considered the experimental criterion of
sensitization.
THE COURSE OF EXPERIMENTAL IMMUNIZATIONS
Forty-five animals were used in a preliminary experiment. These were white,
male guinea pigs ranging in weight from 400—800 grams. They were divided into
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three groups, as follows: group 1 received 1.0 ml. of 1.66% solution of the conju-
gate in physiological saline, intraperitoneally, once a week for four weeks; group
2 received 1.0 ml. of a 1.66% solution of albumin only, once a week for four
weeks; group 3 was held for four weeks with no treatment. One week was allowed
to elapse at the end of the final injection. All animals then received a sensitizing
dose of 25 micrograms of 3-n-pentadecylcatechol (day 1) and on days 8, 10, and
12 challenging doses of 0.9 microgram were applied. Each of these was read for
a reaction 48 hours after application and then observed for an additional 96
hours. Four further sensitizing doses of 25 micrograms of 3-n-pentadecylcatechol
were applied on days 15, 16, 17, and 18, and tests for sensitization again per-
formed on days 25 and 27. These were read as before. No attempt was made to
grade the degree of response; and the reaction was called positive if the test site
showed any erythema. The majority of reactions to the 0.9 microgram dose were
faint to strong erythemas. The results of this experiment are given in Table 1.
Absolute inhibition of sensitization within short periods (25 days) after exposure
to irritant doses of 3-n-pentadecylcatechol was observed in the conjugate-
treated group; after this, variations in the numbers of sensitized animals within
the control groups made the outcome less impressive.
Accordingly, a second experiment, with larger numbers of animals and more
rigorous courses of immunization, was undertaken. One hundred and twenty
white male guinea pigs ranging in body weight from 400—800 grams were divided
into three groups: Group 1, received intraperitoneally, once a week for a period
of five weeks, 1.0 ml. of a 2% solution of the conjugate in physiological saline;
group 2 received intraperitoneally, once a week for five weeks, 1.0 ml. of a 2%
solution of albumin; group 3, held for five weeks without treatment. One week
was allowed to elapse at the end of the last injection. All animals then received
a 25 microgram sensitizing dose of 3-n-pentadecylcatechol, and then tested for
sensitization 8, 10, and 15 days later with 0.9 microgram of allergen. A further
attempt to sensitize was made 14, 15, and 16 days after this, and final testing
TABLE 1
The susceptibility toward sensitization by 3-n-pentadecylcatechol of guinea pigs previously
treated with 66.4 milligrams of albumin-5-n-pentadecylcatechol conjugate, compared with
albumin-treated and untreated animals, expressed as the percentage of animals which were
sensitizable
DAYS AFTER LAST
PROTECTIVE INJECTION
DAYS AFTER LAST
ATTEMPT TO SENSITIZE
CONJUGATE
TREATED ANIMALS
ALBUMIN
TREATED ANIMALS
UNTREATED
ANIMALS
15 8 0% 40% 46%
17 10 0% 20% 39%
32 7 0% 14% 23%
34 9 13% 43% 23%
Number of animals at end of experiment ... 15 14 13
Number of animals lost in the course of the
experiment 0 1 2
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TABLE 2
The susceptibility toward sensitization by 3-n-pentadecylcatechol of guinea pigs previously
treated with 100 milligrams of albumin-3-n-pentadecylcatechol conjugate, compared with
albumin treated and untreated animals, expressed as the percentage of animals which were
sensitizable
DAYS AFTER LAST
PROTECTIVE INJECTION
DAYS AFTER LAST
ATTEMPT TO SENSITIZE
CONJUGATE
TREATED ANIMALS
ALBUMIN
TREATED ANIMALS
UNTREATED
ANIMALS
15 8 8% 44% 45%
17 10 30% 69% 76%
19 12 11% 36% 42%
43 36 24% 61% 57%
45 38 30% 74% 79%
Number of animals at end of experiment . . 37 39 39
Number of animals lost during the course of
the experiment 3 1 1
was carried out a week later. Each test was read 48 hours after application of
allergen, then daily for an additional 96 hours. Results are given in Table 2.
The percentage of each group of animals found susceptible to sensitization
varied considerably over the experimental period. However, the group of animals
which had received injections of allergen conjugate always showed much lower
incidence of sensitivity than either of the control groups.
DISCUSSION
Clearly, the parenteral injection of 3-n-pentadecylcatechol-albumin conjugate
confers upon guinea pigs some resistance to subsequent contact sensitization by
3-n-pentadecylcatechol. In guinea pigs, as in humans, there is a great variability
in susceptibility toward sensitization as well as in capacity to maintain sensitivity
once it is induced. This is, perhaps, due to inheritable differences (7). It is prob-
able that our results reflect this variability, but in any case the protective effect
of allergen conjugate is sufficiently marked that no statistical analysis of the
data is necessary.
It seems reasonable that similar effects of longer duration may be obtailled
by better methods of inciting circulating antibodies to allergen-protein conju-
gates, i.e., Freund's adjuvant technic.
SUMMARY
The parenteral injection of conjugates of 3-n-pentadecylcatechol with human
serum albumin into guinea pigs resulted in resistance to subsequent sensitization
(of the allergic contact type) by 3-n-pentadecylcatechol.
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